Psychopharmacology and personality disorder: Treatment or enhancement?

An in-depth examination into the application of psychopharmacology in the treatment of personality disorders highlights the multifaceted debates about using medication for personality enhancement. Proponents argue that underlying biological disturbances might be at the heart of behavioral anomalies, and psychotropics could offer remedies. There's a perspective that positions psychopharmaceuticals as means for self-creation, allowing individuals to align their identities with their aspirations. However, counter-views voice concerns about the potential erasure of one's genuine self and the looming societal push towards medicinal conformity. Additionally, worries about the adverse impacts of medication, including potential long-term detriment, persist. The inclination of society to prioritize personality traits while underestimating situational factors adds another layer of complexity. Central to the discourse is the nuanced relationship between different layers of self—from the intrinsic, embodied experience to the externally influenced narrative identity. Ethical dilemmas, rooted in discussions around personal authenticity versus societal norms and the provocative proposition of perceiving certain personality disorders as moral rather than medical deficiencies, emerge. We emphasize the importance of an individualized, ethically-balanced approach in employing psychotropics for personality disorders.